GelSana Therapeutics
PrivateLast Round
Seed Round
Mar 6, 2026
Total Funding Raised
$7.9M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
GelSana Therapeutics is a biomaterials company developing novel hydrogel wound dressings designed to reduce inflammation and provide sustained drug delivery for chronic wounds.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GelSana Therapeutics Comparables
Compare GelSana Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioMimir Inc. | 80% | |
| Omeza | 79% | |
| Tempo Therapeutics, Inc. | 78% | |
GelSana Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 6, 2026 | ||||
| Grant | Jul 14, 2025 | ||||
| Accelerator | Jun 5, 2025 | ||||
| Grant | Sep 5, 2024 | ||||
| Seed | Feb 19, 2024 | ||||
Grant | Nov 16, 2023 |
GelSana Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Arthritis and Musculoskeletal and Skin Diseases | Grant |
| MedTech Innovator | Accelerator |
| NIH RADx | Grant |
| Advanced Industries Accelerator Program | Grant |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Innosphere Ventures | Pre Seed |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Open roles increased to 2, 2.5x the trailing average.
- Jul 13, 2026
Open roles increased from 0 to 2, representing 25% of headcount.
GelSana Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GelSana Therapeutics's valuation, stock price, and market status.